I have been a participant in the clinical trail of AMX 0035 since 2018. Below is the public testimony I gave to the FDA at the hearing. My response to AMX0035 may not be typical, however I believe there were other case similar to mine.
I was diagnosed with ALS in December 2017. I have been a participant in the Centar Clinical Trial sinc…[Read more]